Evidence-based public policy making for medicines across countries: findings and implications for the future
Aim: Global expenditure on medicines is rising up to 6% per year driven by increasing
prevalence of non-communicable diseases (NCDs) and new premium priced medicines for …
prevalence of non-communicable diseases (NCDs) and new premium priced medicines for …
[HTML][HTML] Characterizing medicine quality by active pharmaceutical ingredient levels: a systematic review and meta-analysis across low-and middle-income countries
Substandard and falsified medicines are often reported jointly, making it difficult to recognize
variations in medicine quality. This study characterized medicine quality based on active …
variations in medicine quality. This study characterized medicine quality based on active …
Initiatives and reforms across Scotland in recent years to improve prescribing; findings and global implications of drug prescriptions
S MacBride-Stewart, S McTaggart… - … Journal of Clinical …, 2021 - pureportal.strath.ac.uk
Objective: Global expenditure on medicines is increasing driven by a number of factors.
These include the launch of new premium-priced medicines for complex diseases including …
These include the launch of new premium-priced medicines for complex diseases including …
[HTML][HTML] Identification of substandard and falsified medicines: influence of different tolerance limits and use of authenticity inquiries
C Hauk, N Hagen, L Heide - The American Journal of Tropical …, 2021 - ncbi.nlm.nih.gov
Substandard and falsified medicines have severe public health and socioeconomic effects,
especially in low-and middle-income countries. The WHO has emphasized the need for …
especially in low-and middle-income countries. The WHO has emphasized the need for …
A study of the quality of cardiovascular and diabetes medicines in Malang District, Indonesia, using exposure-based sampling
Background The WHO has warned that substandard and falsified medicines threaten health,
especially in low and middle-income countries (LMICs). However, the magnitude of that …
especially in low and middle-income countries (LMICs). However, the magnitude of that …
[PDF][PDF] Quality of Essential Medicines from Different Sources in Enugu and Anambra, Nigeria
J Gabel, M Lächele, K Sander… - The American …, 2024 - … -europe1.s3.dualstack.eu-west-1 …
This study investigated the quality of 13 essential medicines in the states of Enugu and
Anambra, Nigeria. A total of 260 samples were purchased from licensed pharmaceutical …
Anambra, Nigeria. A total of 260 samples were purchased from licensed pharmaceutical …
Stakeholder perspectives on the demand and supply factors driving substandard and falsified blood pressure lowering medications in Nigeria: a qualitative study
G Shedul, OA Sanuade, EN Ugwuneji, TM Ojo… - BMJ open, 2022 - bmjopen.bmj.com
Objectives Although substandard and falsified (SF) blood pressure (BP) lowering
medications are a global problem, qualitative research exploring factors driving this in …
medications are a global problem, qualitative research exploring factors driving this in …
Quality of medicines and public health in Latin America and the Caribbean (LAC): a review
DC Husaini, F Bolon, N Smith, R Reynolds… - International Journal of …, 2023 - emerald.com
Purpose Increased outsourcing and importation of drugs from different parts of the world to
the Latin America and the Caribbean (LAC) region result in the proliferation of substandard …
the Latin America and the Caribbean (LAC) region result in the proliferation of substandard …
Generic drugs–essential for the sustainability of healthcare systems with numerous strategies to enhance their use
The increasing use of lower-cost multiple sourced medicines (generics) and biosimilars are
essential to attain or retain universal healthcare in the face of continual pressure on …
essential to attain or retain universal healthcare in the face of continual pressure on …
Quality assurance systems of pharmaceutical distributors in low-income and middle-income countries: weaknesses and ways forward
AN Giralt, A Bourasseau, G White, C Pouget… - BMJ global …, 2020 - gh.bmj.com
Introduction Access to quality-assured medicines is an essential prerequisite for universal
health coverage, and pharmaceutical distributors play an important role to assure the quality …
health coverage, and pharmaceutical distributors play an important role to assure the quality …